Untitled
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme - De Giorgi - 2019 - BJU International - Wiley Online Library
Università di Bari, al via la «rivoluzione» dell'oncologia al Policlinico - La Gazzetta del Mezzogiorno
JPM | Free Full-Text | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study | HTML
Tweets with replies by Melissa Bersanelli (@Bersa_Dr_Mel) / Twitter
Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey | PLOS ONE
Loop | Camillo Porta
Giampietro GASPARINI | Managing Director | Oncology
Loop | Camillo Porta
Le nuove terapie contro il tumore al rene - YouTube
Loop | Camillo Porta
Intervista Prof. Camillo Porta - YouTube
Tumore del rene, quali sono le terapie più attuali - YouTube
Medical Oncology - ISPA
Nicola SILVESTRIS | Full professor | Professor | Università degli Studi di Messina, Messina | UNIME - Page 4
Loop | Camillo Porta
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting
Adult Urology | Journal of Urology
thumbnail
Melissa Bersanelli (@Bersa_Dr_Mel) / Twitter
